Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mosekilde

Showing results (81-90 of 394) with videos related to

Pageof 40
Sort By:
Calcified Tissue International|June 1, 1987
Compressive strength, ash weight, and volume of vertebral trabecular bone in experimental fluorosis in pigsL Mosekilde, J Kragstrup, A Richards
Diabetologia|May 24, 2005
Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture riskP Vestergaard, L Rejnmark, L Mosekilde
Calcified Tissue International|August 24, 2006
Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fractureP Vestergaard, L Rejnmark, L Mosekilde
Bone|November 1, 1996
Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosisH Oxlund, L Mosekilde, G Ortoft
Drugs & Aging|June 1, 1995
Epidemiology of osteoporosis. Implications for drug therapyJ Rungby, A Hermann, L Mosekilde
Acta Pathologica Et Microbiologica Scandinavica. Section A, Pathology|January 1, 1978
An evaluation of the quantitative parameters applied in bone histologyF Melsen, B Melsen, L Mosekilde
Nordisk Medicin|December 31, 1997
[Apoptosis: molecular aspects]H Løvschall, M Kassem, L Mosekilde
Metabolic Bone Disease & Related Research|January 1, 1982
Reduced wall thickness of completed remodeling sites in iliac trabecular bone following anticonvulsant therapyJ Kragstrup, F Melsen, L Mosekilde
Journal of Internal Medicine|March 25, 2005
Fracture risk associated with systemic and topical corticosteroidsP Vestergaard, L Rejnmark, L Mosekilde
Calcified Tissue International|July 12, 2005
Reduced relative risk of fractures among users of lithiumP Vestergaard, L Rejnmark, L Mosekilde
Pageof 40

Showing results (81-90 of 394) with videos related to

Sort By:
Pageof 40
Calcified Tissue International|June 1, 1987
Compressive strength, ash weight, and volume of vertebral trabecular bone in experimental fluorosis in pigsL Mosekilde, J Kragstrup, A Richards
Diabetologia|May 24, 2005
Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture riskP Vestergaard, L Rejnmark, L Mosekilde
Calcified Tissue International|August 24, 2006
Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fractureP Vestergaard, L Rejnmark, L Mosekilde
Bone|November 1, 1996
Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosisH Oxlund, L Mosekilde, G Ortoft
Drugs & Aging|June 1, 1995
Epidemiology of osteoporosis. Implications for drug therapyJ Rungby, A Hermann, L Mosekilde
Acta Pathologica Et Microbiologica Scandinavica. Section A, Pathology|January 1, 1978
An evaluation of the quantitative parameters applied in bone histologyF Melsen, B Melsen, L Mosekilde
Nordisk Medicin|December 31, 1997
[Apoptosis: molecular aspects]H Løvschall, M Kassem, L Mosekilde
Metabolic Bone Disease & Related Research|January 1, 1982
Reduced wall thickness of completed remodeling sites in iliac trabecular bone following anticonvulsant therapyJ Kragstrup, F Melsen, L Mosekilde
Journal of Internal Medicine|March 25, 2005
Fracture risk associated with systemic and topical corticosteroidsP Vestergaard, L Rejnmark, L Mosekilde
Calcified Tissue International|July 12, 2005
Reduced relative risk of fractures among users of lithiumP Vestergaard, L Rejnmark, L Mosekilde
Pageof 40